Vitalhub Corp. (TSE:VHI – Free Report) – Research analysts at Cormark increased their FY2025 EPS estimates for Vitalhub in a report issued on Monday, April 15th. Cormark analyst G. Fairweather now anticipates that the company will earn $0.26 per share for the year, up from their prior estimate of $0.24. Cormark currently has a “Buy” rating and a $7.50 target price on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.15 per share.
Vitalhub (TSE:VHI – Get Free Report) last posted its earnings results on Thursday, March 21st. The company reported C$0.03 EPS for the quarter, missing analysts’ consensus estimates of C$0.04 by C($0.01). The company had revenue of C$13.60 million during the quarter, compared to the consensus estimate of C$13.68 million. Vitalhub had a return on equity of 5.78% and a net margin of 8.66%.
Vitalhub Trading Up 3.9 %
VHI stock opened at C$6.60 on Tuesday. The stock has a market capitalization of C$288.49 million, a P/E ratio of 66.00, a price-to-earnings-growth ratio of 0.42 and a beta of 1.21. Vitalhub has a 12 month low of C$2.35 and a 12 month high of C$6.86. The firm has a 50-day moving average price of C$6.03 and a 200-day moving average price of C$4.56.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
- Five stocks we like better than Vitalhub
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- United Airlines Soars on Earnings Beat
- Financial Services Stocks Investing
- J.B. Hunt Hits the Skids: Lower Prices to Come
- What is the Nikkei 225 index?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.